Rockin' HIT Sales Podcast
How CFOs Evaluate HIT: Value, Risk and Business Cases That win
Robin Damschroder, MSHA,FACHE is the CFO of Henry Ford Health
Watch or Listen
Choose your preferred platform:
Also available on all major podcast platforms.
Episode Summary
In this episode of Rockin’ HIT Sales, David Hacker sits down with Robin Damschroder, MHSA, FACHE, CFO at Henry Ford Health System, for a practical conversation on how health systems evaluate digital health, data, and AI-enabled solutions. Robin explains what a CFO looks for beyond the demo: enterprise priority alignment, total cost of ownership, cybersecurity risk, operational impact, change management, workforce implications, and realistic adoption assumptions.
The discussion also explores what separates a credible business case from a shiny proposal, why vendors should be transparent about downside scenarios, and how budget cycles, governance, and implementation readiness shape whether a solution gets funded and scaled. For Health IT companies selling into provider organizations, this episode offers a clear CFO lens on what it takes for a technology investment to become fundable, approvable, and operationally successful.Why This Matters for Health IT Companies
A compelling technology story is not enough to make a Health IT investment fundable. Health-system CFOs evaluate whether the solution aligns with enterprise priorities, fits existing platforms and governance, reduces or improves the organization’s cost structure, and can be implemented successfully without creating hidden costs in people, process, workflow, or change management.
For Health IT companies, that means the business case must go well beyond headline ROI. Vendors should be prepared to explain total cost of ownership, operational and workforce impact, realistic adoption assumptions, downside scenarios, expected payback, and what happens if implementation moves more slowly than planned. Robin makes the point very clearly: if the vendor does not model the downside scenario, the health system will.What You’ll Hear in This Episode
- How a health system CFO evaluates digital health, data, and AI-enabled tools
- Why enterprise priorities and existing platforms matter before a proposal gets serious attention
- What separates a strong business case from a shiny technology pitch
- Why total cost of ownership must include people, process, workflow, and change management
- How vendors should address downside scenarios, adoption risk, and realistic payback
- Why CFOs are not the only decision-makers in complex health system buying decisions
- How budget cycles and near-term cost pressure can shape technology investment decisions
Questions This Episode Answers
What does a health-system CFO look at first when evaluating a new Health IT solution?
The first question is whether the solution aligns with an enterprise priority and the organization’s existing platforms. Large health systems have many possible initiatives competing for attention, so solutions tied to current strategic priorities are far more likely to move forward.
What separates a credible Health IT business case from a technology pitch?
A credible business case looks at total cost of ownership, not just software price or projected ROI. It should account for investment in people and process, operational improvement, patient or consumer engagement, workforce impact, payback period and the broader KPI scorecard the health system will use to judge success.
Why should vendors include downside scenarios in their financial model?
Because health systems will test the assumptions themselves. If adoption, ramp-up, clinician engagement, or implementation takes longer than expected, the payback period and KPIs may change materially. Vendors build credibility by acknowledging those possibilities rather than presenting only the best-case outcome.
Is the CFO the economic buyer and sole decision-maker for Health IT purchases?
Not necessarily. Robin explains that CFOs operate within governance, policies, and organizational processes. The teams responsible for deploying and using the technology also need to understand the outcomes, support the initiative, and own the implementation. Going directly to the top does not eliminate the broader decision process.
How do health-system budget cycles affect Health IT sales?
Timing matters. If a vendor misses the normal budget cycle, the opportunity may be delayed unless the solution becomes a sufficiently important organizational priority. Vendors need to understand where they are in the customer’s priority-setting and governance process rather than assuming a long sales cycle simply reflects slow decision-making.
Can a Health IT investment ever be funded outside the normal budget cycle?
Yes. Health systems may reserve funds for priorities that emerge during the year or for initiatives that are still being evaluated when the annual budget is established. The key is whether the problem and proposed solution have become important enough within the organization’s governance and priority structure.
Why does change management belong in the financial conversation?
Because implementation affects people, roles, workflows, training, culture, and sometimes workforce structure. Those factors influence both total cost and whether the expected benefits will actually materialize. Robin repeatedly emphasizes that technology investment is not just about the technology—it is also about people and process.
What should a Health IT vendor be able to answer before submitting a proposal?
A particularly powerful question from Robin is essentially: how will the solution solve an operating problem while also reducing the health system’s cost structure in the near term? That shifts the conversation from theoretical ROI to affordability and measurable financial impact.
David’s GTM Takeaways for Health IT Vendors
Robin’s comments on total cost of ownership, payback, and downside scenarios connect directly to this white paper on why Health IT sellers should lead with payback period instead of headline ROI.
Download: Rethinking Buyer Conversations – Why Health IT Sellers Should Lead With Payback Period, Not ROI
About the Guest
Robin Damschroder, MHSA, FACHE, is CFO at Henry Ford Health System, where she plays a central role in evaluating major investments across digital health, data, AI, IT, revenue cycle, and operational priorities.
In this conversation, Robin brings a practical finance and enterprise leadership perspective to how health systems assess technology: not just whether a solution is innovative, but whether it aligns with strategic priorities, integrates into core platforms, supports the workforce, reduces cost structure, and can be implemented successfully at scale.Transcript
Prefer to read or download the conversation?